Position in GH
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$375,825
+$143,145 QoQ
Shares Held
2,505
-0.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#395
of 593 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NORDEN GROUP LLC holds $3,533,170 across 7 Diagnostics & Research names. GH ranks #5 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
2,361 | $1,242,924 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,257 | $630,209 | |
| 3 | LH |
Labcorp Holdings Inc.
|
2,079 | $582,120 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
824 | $436,382 | |
| 5 | GH |
Guardant Health, Inc.
This page
|
2,505 | $375,825 | |
| 6 | DHR |
Danaher Corp /De/
|
1,081 | $205,908 | |
| 7 | ADPT |
Adaptive Biotechnologies Corp
|
2,788 | $59,802 |
All Filings in GH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $375,825 | 2,505 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $232,680 | 2,519 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $211,634 | 2,072 | Shares | Sole | 2026-01-13 | |
| No filing history on record for this holder in this stock. | ||||||